Head‐to‐head trials of systemic psoriasis therapies: a systematic review of study design and maximum acceptable treatment differences-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Head‐to‐head trials of systemic psoriasis therapies: a systematic review of study design and maximum acceptable treatment differences

Published:2018-08-05 Issue:1 Volume:33 Page:42-55
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Wan M.T.¹^ORCID,Alvarez J.¹,Shin D.B.¹,Dommasch E.D.²,Wu J.J.³,Gelfand J.M.¹⁴

Affiliation:

1. Department of Dermatology University of Pennsylvania Perelman School of Medicine Philadelphia PA USA

2. Department of Dermatology and Harvard Medical School Beth Israel Deaconess Medical Center Boston MA USA

3. Department of Dermatology Kaiser Permanente Los Angeles Medical Center Los Angeles CA USA

4. Department of Biostatistics Epidemiology and Informatics University of Pennsylvania Perelman School of Medicine Philadelphia PA USA

Funder

National Institutes of Health

National Psoriasis Foundation

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.15174

Reference75 articles.

1. Placebo versus Best-Available-Therapy Control Group in Clinical Trials for Pharmacologic Therapies: Which Is Better?

2. Physicians’ preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugs

3. Decline In Placebo-Controlled Trial Results Suggests New Directions For Comparative Effectiveness Research

4. Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture

5. Randomized Clinical Trials for Psoriasis 1977–2000: The EDEN Survey

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologika in der dermatologischen Praxis – eine 20-jährige Geschichte;Aktuelle Dermatologie;2024-05-13

2. Criteria used to define tumor necrosis factor-alpha inhibitors failure in patients with moderate-to-severe psoriasis: a systematic literature review;Annals of Medicine;2023-04-04

3. Treatment of chronic plaque psoriasis with herbal Unani formulations: A randomized control trial of efficacy and safety;Journal of Ethnopharmacology;2022-10

4. Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial;American Journal of Clinical Dermatology;2022-08-07

5. Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate‐to‐severe plaque psoriasis naïve to systemic treatment;British Journal of Dermatology;2020-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3